Get started
Advanced Enzyme Technologies LtdAdvanced Enzyme Technologies LtdAdvanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Ltd

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasDiscussionsTechnicalsForecastSeasonalsETFs

ADVENZYMES trade ideas

Advanced Enzyme Technologies Ltd_ Short-termAdvanced Enzyme Technologies Ltd (ADVENZYMES) – Technical Analysis Current Price: ₹355–356 (as of Aug 29, 2025) Stock has rallied +18% in 2 sessions, showing strong momentum. Price has broken above key resistance at ₹336 (pivot), turning it into support. 📈 Indicators & Momentum Moving Averages (MA20/50/200): Price is trading above all major EMAs, confirming bullish trend. RSI (14): ~68 → approaching overbought zone, but still has room to push higher. ADX (14): >30 → trend strength is strong and valid. Volume: Delivery volume spiked 7.5x above average, confirming institutional interest. 🧭 Chart Structure Breakout above ₹336 pivot signals start of a fresh uptrend. A daily close above ₹380 may open the path toward ₹410 – ₹455 zone. Watch for consolidation near ₹350–₹360 before next leg. ⚡ Trading View Bias: Bullish as long as price stays above ₹336. Short-Term Target: ₹380 → ₹410 Medium-Term Target: ₹455 Invalidation: Close below ₹336 pivot may weaken trend. Disclaimer: This is a technical analysis study for educational purposes only — not investment advice. Always do your own research before trading.
NSE:ADVENZYMESLong
by Vijay_Trade
# ADVENZYMES Price Analysis (July 2025)Current Price and Trading Pattern Advanced Enzyme Technologies Ltd (ADVENZYMES) is trading near ₹335 in late July 2025. The price range for recent sessions is ₹331–₹346, with daily swings generally limited to 1–2%. Trading volumes are average for its segment, indicating steady, if unspectacular, investor interest. The 52-week price band extends from a low of ₹258 to a high of almost ₹571, showing that the stock has experienced significant volatility and a substantial correction from last year’s peak. ## Performance Overview - **1-Month:** The stock has been consolidating, exhibiting minimal directional bias and relatively stable prices. - **6-Month:** There has been a notable decline, significantly underperforming its sector benchmarks. The price remains below important moving averages, indicating sustained technical weakness. - **12-Month:** ADVENZYMES has declined approximately 30% over the past year, in marked contrast to the modest gains seen in broader equity indices. ## Financials and Valuation - **Market Capitalization:** Approximately ₹3,750–3,800 crore. - **Earnings per Share (TTM):** About ₹11.7. - **P/E Ratio:** Nearly 28, somewhat below the specialty chemicals sector average, likely reflecting recent challenges in growth and profitability. - **P/B Ratio:** Close to 2.6. - **Dividend Yield:** Roughly 1.5–1.6%, with an interim dividend of ₹4 per share recently declared. ## Business Health ADVENZYMES is a leading manufacturer of enzymes and probiotics with global clients across healthcare, food processing, and specialty industrial markets. The latest financial results show minor revenue growth but declining net profits and operating margins, primarily due to increased costs and a shift in the product mix. Earnings per share have reached multi-quarter lows, prompting concern about operational efficiency and cost management. ## Shareholder Structure - **Promoters:** Hold about 43% of shares. - **Institutional Investors (FII/DII):** Approximately 26%. - **Retail/Public:** The remaining shares. ## Risk and Volatility - The stock is roughly three times as volatile as major market indices, making it a high-beta investment. - Liquidity is sufficient for the usual investment sizes, but price performance has lagged sector peers over the past year. ## Technical and Sector Comparison ADVENZYMES is trading below its major short-, medium-, and long-term moving averages, highlighting a bearish trend. In comparison, the specialty chemicals sector has had mild positive momentum, which makes ADVENZYMES a notable underperformer in its peer group. ## Outlook The company’s fundamentals remain sound from a market positioning perspective, bolstered by a track record of dividend payment and global reach. However, the recent deterioration in revenue growth, margins, and earnings clouds the short-term outlook. The technical setup stays negative, and further consolidation or downside is possible unless there is clear operational improvement or sector-wide momentum. Investors should keep a close watch on margin trends, revenue acceleration, and cost control initiatives as signals for recovery.
NSE:ADVENZYMESLong
by KamalKJoshi
Advanced Enzyme Technologies Ltd ₹ 330 1.46% 21 Jul 11:07 a.m.#chart_sab_kuch_bolta_hai* If price breaks above Rs 338. in daily timeframe, then 1st Target is RS 360 Stoploss your own. DISCLAIMER: I am not a SEBI-registered advisor. The content shared, including charts, ideas, and analysis, is purely for educational and informational purposes only. This should not be considered as financial or investment advice. Please do your own research or consult with a SEBI-registered professional before making any trading or investment decisions. I will not be responsible for any losses incurred.
NSE:ADVENZYMES
by Bukharifazalabbask
1
Advanced Enzyme Technologies Ltd ₹ 334 0.74% 11 Jul 9:57 a.m.Advanced Enzyme Technologies Ltd ₹ 334 0.74% 11 Jul 9:57 a.m. #chart_sab_kuch_bolta_hai* If price breaks above RS 341. in daily timeframe, then 1st Target is RS 357 2nd target is RS --Stoploss your own. DISCLAIMER: I am not a SEBI-registered advisor. The content shared, including charts, ideas, and analysis, is purely for educational and informational purposes only. This should not be considered as financial or investment advice. Please do your own research or consult with a SEBI-registered professional before making any trading or investment decisions. I will not be responsible for any losses incurred.
NSE:ADVENZYMES
by Bukharifazalabbask
Bullish structure : ADVENZYMES - Ascending Triangle ### 🧾 **Chart Type & Time Frame** * **Daily Candlestick Chart** (1D) * **Exchange**: NSE (India) * **Latest Price**: ₹305.95 (+6.12% on the day) * **Volume**: 726.33K (well above average — **457.83%** Volume Run Rate) --- ### 📉 **Trend Analysis** * **Primary Trend**: Downtrend from ₹517.90 (high in Nov 2024) to a bottom around ₹257.90 (March 2025). * **Current Action**: Price is showing a **potential reversal** from a long downtrend. * **Higher Lows Pattern**: Since the bottom at ₹257.90, price has made: * ₹261.10 → ₹266.00 → ₹273.65 → ₹306.85 → (Now breaking above ₹306.75) This forms an **ascending triangle** pattern (bullish bias). --- ### 📊 **Indicators & Overlays** #### 1. **Moving Averages (EMA)** * EMA levels: * EMA-20: ₹290.07 * EMA-50: ₹292.01 * EMA-100: ₹310.17 * EMA-200: ₹337.89 **Current price (₹305.95)** is: * Above EMA-20 & EMA-50 → Short-term bullish * Slightly below EMA-100 and EMA-200 → Mid-to-long term resistance still ahead If it breaks and sustains above EMA-100 & EMA-200, stronger uptrend confirmation. --- #### 2. **Fibonacci Retracement (from ₹571 to ₹258)** * **Key levels:** * 23.6% → ₹497.15 * 38.2% → ₹451.45 * 50% → ₹414.55 * 61.8% → ₹377.65 * 78.6% → ₹325.05 *(Immediate target zone)* **Price approaching 78.6% retracement (₹325.05)**, which is a key resistance zone. A breakout here can push prices towards ₹337-₹350 zone. --- #### 3. **RSI (14, Close)** * Current RSI: **\~62.90** * Moving above the 60 level, indicating building bullish momentum. * Still not overbought (>70), room for upward move exists. --- #### 4. **Volume** * Spike in volume on the breakout day → Strong confirmation. * Today's volume: **726.33K** vs average 163.81K → Over **4x average**. --- ### 📌 **Support & Resistance Levels** #### Key Resistance: * ₹306.85 (recent swing high) → **Broken today** * ₹325.05 (Fibo 78.6%) * ₹337.89 (EMA-200) * ₹350–365 (previous price clusters) #### Key Support: * ₹293–296 (previous resistance, now support) * ₹273.65 (swing low) * ₹258 (Fibo 100% level) --- ### 🔺 **Pattern Observed** * **Ascending Triangle** breakout confirmed with high volume * Bullish structure: Higher lows with flat resistance (₹306 zone) * If price sustains above ₹306, could target ₹325–₹350 short term --- ### 🔮 **Conclusion & View** ✅ **Bullish Bias in Short Term** * Breakout of important level with strong volume * RSI supportive * EMA crossovers may follow if trend continues 📈 **Short-Term Target**: ₹325 → ₹337 → ₹350 📉 **Stop Loss**: ₹293 or ₹280 (based on risk appetite) 📌 Disclaimer: This analysis is for educational and informational purposes only and does not constitute investment advice. Please do your own research or consult with a financial advisor before making any trading decisions. Markets are subject to risks.
NSE:ADVENZYMESLong
by vkj123
Advanced Enzymes: Fresh Breakout Above Key ResistanceNSE:ADVENZYMES Made a Beautiful Chart Structure, Gave Fresh Breakout Above Key Resistance, Could Now Trigger 20% Rally - Time to Buy the Dip? Pattern Recognition and Base Formation: NSE:ADVENZYMES has been consolidating in a well-defined rectangular trading range for the past 3-4 months, oscillating between ₹260-305 levels. This sideways consolidation represents a healthy digestion phase after the stock's earlier decline from highs around ₹350. The most recent price action shows a decisive breakout above the ₹305 resistance level on strong volume expansion, suggesting institutional participation and potential trend reversal. The stock appears to be forming a classic "rectangle breakout" pattern, which typically signals continuation of the prevailing trend or reversal from consolidation. Key Technical Levels Analysis: Key Support Levels: - Immediate Support: ₹285-290 (recent breakout zone, now expected to act as support) - Major Support: ₹270-275 (mid-range consolidation area with multiple touches) - Critical Support: ₹260-265 (lower boundary of the rectangle pattern) - Ultimate Floor: ₹257.90 (52-week low and absolute support) Key Resistance Levels: - Immediate Resistance: ₹315-320 (psychological round number resistance) - Next Target: ₹330-335 (halfway to previous highs) - Major Target: ₹350 (previous high retest) - Extension Target: ₹365-370 (measured move from rectangle pattern) Volume Spread Analysis: Today's volume surge to 776.33K shares represents nearly 5x the average daily volume of 162.61K, indicating significant institutional interest. This volume expansion accompanying the breakout is a critical confirmation signal that validates the technical setup. The volume pattern during the consolidation phase showed typical accumulation characteristics - higher volume during declines and moderate volume during bounces, until today's breakout, which shows strong participation. Technical Pattern Assessment: Primary Pattern: Rectangle/Trading Range Breakout - Formation Period: February 2025 - May 2025 - Range: ₹260-305 (approximately ₹45 range) - Breakout Level: ₹305 (achieved with volume confirmation) - Measured Target: ₹350+ (adding range height to breakout point) The pattern shows multiple tests of both support and resistance levels, indicating a mature base formation with strong hands accumulating positions during weakness. Trade Setup: Setup Classification: Breakout Play with Volume Confirmation Entry Strategies: - Aggressive Entry: ₹300-305 (current levels on any minor pullback) - Conservative Entry: ₹285-290 (on retest of breakout level for better risk-reward) - Value Entry: ₹275-280 (if deeper pullback occurs, though less likely given volume surge) Position Sizing: - Initial Allocation: 1-2% of portfolio (given setup quality and volume confirmation) - Scaling Strategy: Add on pullbacks to support levels Profit Taking Approach: - Target 1: ₹325-330 (6-8% upside) - Book 30% of position - Target 2: ₹345-350 (12-15% upside) - Book 40% of position - Target 3: ₹365-370 (18-20% upside) - Hold remaining 30% for potential extension Risk Management Framework: - Tight Stop: ₹295 (3-4% downside for short-term traders) - Swing Stop: ₹285 (7-8% downside for position traders) - Pattern Stop: ₹275 (10% downside - invalidates bullish setup if breached) Sectoral and Fundamental Backdrop: NSE:ADVENZYMES operates in the speciality chemicals and biotechnology space, focusing on enzyme manufacturing for various industrial applications. The sector dynamics are currently favourable due to: Industry Tailwinds: - Growing demand for sustainable and eco-friendly industrial processes - Increasing adoption of enzyme-based solutions in food processing, textiles, and pharmaceuticals - Government push for bio-based manufacturing and green chemistry initiatives - Rising exports of speciality chemicals from India Company Specific Factors: - Strong research and development capabilities in enzyme technology - Diversified application portfolio reducing single-sector dependency - Established client relationships in domestic and international markets - Beneficiary of the "Make in India" initiative in speciality chemicals Fundamental Support: - Consistent revenue growth trajectory in recent quarters - Improving operating margins due to product mix optimization - Strong balance sheet with manageable debt levels - Increasing focus on value-added enzyme products Risk Assessment: Bullish Catalysts: - Volume-confirmed breakout from 3-month consolidation - Strong sectoral tailwinds supporting long-term growth - Technical pattern completion with clear target levels - Established support base providing downside protection Risk Factors: - Broader market volatility could impact momentum stocks - The speciality chemicals sector's sensitivity to raw material costs - Global economic slowdown affecting industrial demand - Competition from larger multinational enzyme manufacturers My Take and Recommendation: NSE:ADVENZYMES presents a compelling technical setup with the stock breaking out of a well-established 3-month trading range on exceptional volume. The combination of strong technical patterns, sectoral tailwinds, and reasonable fundamental backdrop creates an attractive risk-adjusted opportunity. The immediate focus should be on the stock's ability to sustain above the ₹305 breakout level and build momentum toward the ₹325-330 resistance zone. Any pullback to the ₹285-290 area would offer an excellent secondary entry point with improved risk-reward parameters. Given the volume confirmation and sector dynamics, the stock appears positioned for a potential move toward its previous highs around ₹350, representing approximately 15% upside from current levels. However, traders should maintain disciplined risk management and respect the established support levels to protect capital in case of adverse market conditions. The next few trading sessions will be crucial to determine whether this breakout has the sustainability to trigger the next leg of the rally or if it represents a false breakout requiring reassessment of the bullish thesis. Keep in the Watchlist. NO RECO. For Buy/Sell. 📌Thank you for exploring my idea! I hope you found it valuable. 🙏FOLLOW for more 👍BOOST if you found it useful. ✍️COMMENT below with your views. Meanwhile, check out my other stock ideas on the right side until this trade is activated. I would love your feedback. Disclaimer: "I am not a SEBI REGISTERED RESEARCH ANALYST AND INVESTMENT ADVISER." This analysis is intended solely for informational and educational purposes and should not be interpreted as financial advice. It is advisable to consult a qualified financial advisor or conduct thorough research before making investment decisions.
NSE:ADVENZYMESLong
by Karanshah137
6
Advanced Enzyme Technologies Limited is engaged in the business Market Position The Co. is the 1st Indian enzyme company with 2nd highest market share in India. It is the 2nd listed integrated enzyme player globally. Product Portfolio The company manufactures and markets over 400+ proprietary products developed from 68+ enzymes and probiotics. Business Segments 9MFY24 Human Healthcare (68%) The company provides proprietary enzyme products and customized enzyme solutions to various pharmaceutical and nutraceutical companies in India, North America, Asia (ex-India), Europe, and other countries globally. Animal Nutrition (11%) It provides enzyme-based feed additives for the animal nutrition industry, mainly catering to poultry and swine. Animal Nutrition product offering enables animals to maximize the nutrients they absorb from the feed which helps the customers to reduce the feed costs. Industrial Bioprocessing (15%) The company produces non-food processing enzymes for various industries such as textiles, leather, detergent, and pulp & paper, which are used in the manufacturing of a wide range of products. It also produces food processing enzymes which are essential for enhancing food and beverage products. Specialized Manufacturing (6%) In this segment, the Co. manufactures products based on effervescent technology. These effervescent products extend solutions in Nutraceutical, Pharmaceutical, Bakery, Washing solutions, and other Speciality products. International Presence Co. is present in 45+ countries and caters to 700+ customers worldwide. 9MFY24 India - 50% Americas - 33% Europe - 6% Asia (Excluding India) - 7% Rest of the World - 4%
NSE:ADVENZYMES
by dpkrthvideos
ADVANCED ENZYME LTD ANALYSISFOR LEARNING PURPOSE ADVANCED ENZYME LTD - The current price of ADVANCED ENZYME LTD is 503.00 rupees I am going to buy this stock because of the reasons as follows- 1. Its coming out from a good long base. 2. It made ATH by breaking resistance of last 3 years and now retesting that level 3. In last 2 years, it has shown some better strength and probably it can continue in coming weeks 4. The risk and reward is favourable 5. Recent numbers are improving slowly but surely but it has got lot to prove. 6. This stock has got potential to perform and it has not done much in comparison to many other stocks. I will buy it with minimum target of 35-40% and then will trail after that. My SL is at 439 rupees I will be managing my risk.
NSE:ADVENZYMESLong
by Its_Bhushan
ADVENZYMES - Breakout Setup, Move is ON..NSE:ADVENZYMES ✅ #ADVENZYMES trading above Resistance of 485 ✅ Next Resistance is at 642 ✅ Trailing Support is at 341 Related charts: Charts are self-explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:ADVENZYMES
by Sandeep_Aggarwal
1
BUY TODAY SELL TOMORROW for 5% By Kapil-MittalDON’T HAVE TIME TO MANAGE YOUR TRADES? - Take BTST trades at 3:25 pm every day - Try to exit by taking 4-7% profit of each trade - SL can also be maintained as closing below the low of the breakout candle Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that 90% of the stocks give most of the movement in just 1-2 days and the rest of the time they either consolidate or fall Trendline Breakout in ADVENZYMES BUY TODAY SELL TOMORROW for 5%
NSE:ADVENZYMES
by Kapil-Mittal
4
ADVANCE ENZYMES - BREAKOUT WITH VOLUME Advanced Enzyme Technologies Ltd. is an interesting chart in momentum with following 1. RSI on all time frames above 60 2. Price crossed above a box consolidation zone of 404 level last week 3. Breakout of six month long consolidation with high volume. 4. Narrowing Bollinger Bands on weekly chart 5. Price moving on upper Bollinger band on daily chart can be a good risk reward option with buy on dips and dips only Lets See How it Evolves. Disclaimer: NOT A BUY / SELL RECOMMENDATION I am not an expert I just share interesting charts here for educational purpose and not to be taken as buy/sell recommendation. Please seek expert opinion before investing and trading as trading/ investing in market is subject to market risks. I do not hold any position in the stock as on date but I may look to buy on dips with my own Risk Reward matrix.
NSE:ADVENZYMESLong
by purisonshuf
ADVENZYMES Near Resistance in Channel.. cautious Nowwe delve into the dynamic world of growing stocks, providing valuable analysis and commentary on significant levels that traders need to keep an eye on. From crucial support and resistance zones to potential breakout points, we aim to equip you with the insights you need to navigate the stocks with confidence. Stay tuned for regular updates, technical analysis, and market commentary to help you stay ahead of the curve in your trading journey. Whether you're a seasoned investor or just dipping your toes into the market, our publication strives to provide actionable insights to enhance your trading decisions. Join us as we uncover the nuances of all stocks & indices and uncover opportunities in this ever-evolving market landscape. Don't miss out on the latest analysis – hit that follow button and embark on your journey to trading success with us
NSE:ADVENZYMES
by JogeshProTrader
5
ADVENZYMES | Swing Trade📊 DETAILS Sector: Pharmaceuticals & Drugs Mkt Cap: 3,599 cr Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes. TTM PE : 30.86 (Average PE) Sector PE : 32.61 Beta : 0.67 📚 INSIGHTS Strong Performer Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators 6.78% away from 52 week high Underperformer - Advanced Enzyme Technologies down by -1.61% v/s NIFTY 50 down by -1.54% in last 1 month 📈 FINANCIALS Piotroski Score of 5/9 indicates Average Financials Disclaimer: This analysis is for educational purposes only, and I'm not a SEBI registered analyst. If you found this analysis helpful, I encourage you to like and share it. Your observations and comments are also welcomed below. Your support, likes, follows, and comments motivate me to consistently share valuable insights with you. 🔍 More Analysis & Trade Setups 🔍 For more technical analysis and trade setups, make sure to follow me on TradingView: www.tradingview.com
NSE:ADVENZYMESLong
by Munish_Jain
4